Evidence map›Paper›PMID 40614169›Full record

ArticleThe Journal of infectious diseases2026

Hygromycin A Treatment of Borrelia burgdorferi-Infected Peromyscus leucopus Suggests Potential as a Reservoir-Targeted Antibiotic.

Stephanie S You, Muskan Shrestha, Jeffrey S Bourgeois, Luke H Clendenen, Nadja Leimer, Kim Lewis, Sam R Telford, Linden T Hu

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Rodent-Borne Parasites and Human Disease: A Growing Public Health Concern.Animals : an open access journal from MDPI · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephanie S YouTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.
Muskan ShresthaTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.
Jeffrey S BourgeoisTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0001-9037-8418
Luke H ClendenenTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.
Nadja LeimerAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.
Kim LewisAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.
Sam R TelfordTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-4548-8663
Linden T HuTufts Lyme Disease Initiative, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-1659-5558

Funding

Heritable immunization of the white-footed mouse reservoir of Lyme diseaseR01AI152209 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESVELT, KEVIN, JAENISCH, RUDOLF · 2021 to 2025
$4.7M
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferiR01AI152210 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T, LEWIS, KIM · 2020 to 2025
$3.9M
Identifying Determinants of Borrelia burgdorferi and Peromyscus leucopus symbiosisF32AI179104 · NIAID · TUFTS UNIVERSITY BOSTON · PI BOURGEOIS, JEFFREY · 2023 to 2025
$143k
NIH HHS F32AI179104NIH HHS R01AI152209NIH HHS R01AI152210
6 · The paper itself

Abstract

Lyme disease spirochetes are maintained in natural reservoirs before spilling over into human populations. Targeting these reservoirs with vaccinations or antibiotics could impact the Borrelia burgdorferi enzootic cycle and reduce the risk of human Lyme disease. In this work we report that the narrow-spectrum antibiotic hygromycin A is sufficient to disrupt B burgdorferi transmission from the main eastern US reservoir, Peromyscus leucopus, to ticks. Additionally, hygromycin A-containing baits can clear B burgdorferi from P leucopus. These studies lay the foundation for the use of hygromycin A as a reservoir-targeted antibiotic to eradicate B burgdorferi in the wild.

Indexed as

Anti-Bacterial AgentsBorrelia burgdorferiHygromycin BLyme DiseasePeromyscusAnimalsCinnamatesDisease ReservoirsAnti-Bacterial AgentsCinnamateshygromycin AHygromycin BantibioticsBorrelia burgdorferiBorreliella burgdorferiLyme diseasereservoir

Identifiers

PMID40614169
PMCPMC12811853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.